TARS
Tarsus Pharmaceuticals, Inc.
NASDAQ · Healthcare · Biotechnology · US
$90.78
+9.10%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- 57.56x
- P/E 2028E
- 17.85x
- P/S forward
- 4.99x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 11.49x
- Price / sales
- 6.57x
- Price / cash flow
- 49.98x
Enterprise value
- Enterprise value
- $3.6B
- EV / sales
- 5.97x
- EV / EBITDA
- -102.87x
- EV / EBIT
- -74.64x
- Market cap
- $4.0B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026